Li Weiming, Johnson Scott A, Shelley William C, Ferkowicz Michael, Morrison Paul, Li Yanjun, Yoder Mervin C
Herman B. Wells Center for Pediatric Research, Cancer Research Institute, 1044 W Walnut St, R4-419, Indianapolis, IN 46202, USA.
Blood. 2003 Dec 15;102(13):4345-53. doi: 10.1182/blood-2003-03-0729. Epub 2003 Jul 31.
The embryonic origin and development of hematopoietic and endothelial cells is highly interdependent. We hypothesized that primary endothelial cells from murine yolk sac and para-aortic splanchnopleura (P-Sp) may possess the capacity to expand hematopoietic stem cells (HSCs) and progenitor cells ex vivo. Using Tie2-GFP transgenic mice in combination with fluorochrome-conjugated monoclonal antibodies to vascular endothelial growth factor receptor-2 (Flk1) and CD41, we have successfully isolated pure populations of primary endothelial cells from 9.5-days after coitus (dpc) yolk sac and P-Sp. Adult murine bone marrow Sca-1+c-Kit+lin- cells were cocultured with yolk sac or P-Sp Tie2-GFP+Flk-1+CD41- endothelial cell monolayers for 7 days and the total number of nonadherent cells increased 47- and 295-fold, respectively, and hematopoietic progenitor counts increased 9.4- and 11.4-fold, respectively. Both the yolk sac and P-Sp endothelial cell cocultures facilitated long-term (> 6 months) HSC competitive repopulating ability (2.8- to 9.8-fold increases, respectively). These data suggest that 9.5-dpc yolk sac- and P-Sp-derived primary Tie2-GFP+Flk-1+CD41- endothelial cells possess the capacity to expand adult bone marrow hematopoietic progenitor cell and HSC repopulating ability ex vivo.
造血细胞和内皮细胞的胚胎起源与发育高度相互依存。我们推测,来自小鼠卵黄囊和主动脉旁脏壁中胚层(P-Sp)的原代内皮细胞可能具有在体外扩增造血干细胞(HSCs)和祖细胞的能力。利用Tie2-GFP转基因小鼠,结合荧光染料偶联的抗血管内皮生长因子受体-2(Flk1)和CD41单克隆抗体,我们成功地从交配后9.5天(dpc)的卵黄囊和P-Sp中分离出了原代内皮细胞的纯群体。将成年小鼠骨髓Sca-1+c-Kit+lin-细胞与卵黄囊或P-Sp Tie2-GFP+Flk-1+CD41-内皮细胞单层共培养7天,非贴壁细胞总数分别增加了47倍和295倍,造血祖细胞计数分别增加了9.4倍和11.4倍。卵黄囊和P-Sp内皮细胞共培养均促进了长期(>6个月)的造血干细胞竞争重建造血能力(分别增加2.8至9.8倍)。这些数据表明,来自9.5 dpc卵黄囊和P-Sp的原代Tie2-GFP+Flk-1+CD41-内皮细胞具有在体外扩增成年骨髓造血祖细胞和造血干细胞重建造血能力的特性。